A Clinically Applicable Gene-Expression Classifier Reveals Intrinsic and Extrinsic Contributions to Consensus Molecular Subtypes in Primary and Metastatic Colon Cancer.
Animals
Biomarkers, Tumor
/ genetics
Clinical Trials, Phase II as Topic
Clinical Trials, Phase III as Topic
Cohort Studies
Colorectal Neoplasms
/ classification
Female
Gene Expression Profiling
/ methods
Gene Expression Regulation, Neoplastic
Humans
Mice
Mice, Inbred NOD
Molecular Typing
/ methods
Mutation
Neoplasm Metastasis
Neoplasm Staging
Tumor Cells, Cultured
Xenograft Model Antitumor Assays
Journal
Clinical cancer research : an official journal of the American Association for Cancer Research
ISSN: 1557-3265
Titre abrégé: Clin Cancer Res
Pays: United States
ID NLM: 9502500
Informations de publication
Date de publication:
15 07 2019
15 07 2019
Historique:
received:
14
09
2018
revised:
29
01
2019
accepted:
15
04
2019
pubmed:
21
4
2019
medline:
23
9
2020
entrez:
21
4
2019
Statut:
ppublish
Résumé
Four consensus molecular subtypes (CMS1-4) of colorectal cancer were identified in primary tumors and found to be associated with distinctive biological features and clinical outcomes. Given that distant metastasis largely accounts for colorectal cancer-related mortality, we examined the molecular and clinical attributes of CMS in metastatic colorectal cancer (mCRC). We developed a colorectal cancer-focused NanoString-based CMS classifier that is ideally suited to interrogate archival tissues. We successfully used this panel in the CMS classification of formalin-fixed paraffin-embedded (FFPE) tissues from mCRC cohorts, one of which is composed of paired primary tumors and metastases. Finally, we developed novel mouse implantation models to enable modeling of colorectal cancer Using our classifier, we find that the biological hallmarks of mCRC, including CMS, are in general highly similar to those observed in nonmetastatic early-stage disease. Importantly, our data demonstrate that CMS1 has the worst outcome in relapsed disease, compared with other CMS. Assigning CMS to primary tumors and their matched metastases reveals mostly concordant subtypes between primary and metastasis. Molecular analysis of matched discordant pairs reveals differences in stromal composition at each site. The development of two novel We describe the utility of a NanoString panel for CMS classification of FFPE clinical samples. Our work reveals the impact of intrinsic and extrinsic factors on colorectal cancer heterogeneity during disease progression.
Identifiants
pubmed: 31004000
pii: 1078-0432.CCR-18-3032
doi: 10.1158/1078-0432.CCR-18-3032
doi:
Substances chimiques
Biomarkers, Tumor
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
4431-4442Informations de copyright
©2019 American Association for Cancer Research.